The tRNA Epitranscriptome and Diabetes: Emergence of tRNA Hypomodifications as a Cause of Pancreatic β-Cell Failure

Endocrinology. 2019 May 1;160(5):1262-1274. doi: 10.1210/en.2019-00098.

Abstract

tRNAs are crucial noncoding RNA molecules that serve as amino acid carriers during protein synthesis. The transcription of tRNA genes is a highly regulated process. The tRNA pool is tissue and cell specific, it varies during development, and it is modulated by the environment. tRNAs are highly posttranscriptionally modified by specific tRNA-modifying enzymes. The tRNA modification signature of a cell determines the tRNA epitranscriptome. Perturbations in the tRNA epitranscriptome, as a consequence of mutations in tRNAs and tRNA-modifying enzymes or environmental exposure, have been associated with human disease, including diabetes. tRNA fragmentation induced by impaired tRNA modifications or dietary factors has been linked to pancreatic β-cell demise and paternal inheritance of metabolic traits. Herein, we review recent findings that associate tRNA epitranscriptome perturbations with diabetes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Diabetes Mellitus / genetics*
  • Diabetes Mellitus / metabolism
  • Humans
  • Insulin-Secreting Cells / metabolism*
  • Models, Genetic
  • Mutation
  • Protein Biosynthesis*
  • RNA Processing, Post-Transcriptional*
  • RNA, Transfer / genetics*
  • RNA, Transfer / metabolism
  • tRNA Methyltransferases / genetics
  • tRNA Methyltransferases / metabolism

Substances

  • RNA, Transfer
  • tRNA Methyltransferases